Open-angle glaucoma is an eye disease that causes a gradual loss of vision. It is the most common type of glaucoma, a set of eye diseases that affect the eye's optic nerve. The optic nerve is ...

Simple reaction time tasks given to patients living with glaucoma had different response times based on whether the task was visual or auditory, according to a new study published in the European ...

H-1337 is under clinical development by D. Western Therapeutics Institute and currently in Phase II for Open-Angle Glaucoma.

Background: To investigate the levels of nitric oxide (NO) markers in plasma and aqueous humour of patients with primary open angle glaucoma (POAG) and their relation to ocular perfusion pressure.

Dihydropyridine CCBs may raise the risk of glaucoma, suggests a study published in the Ophthalmology Glaucoma.A study was ...

Shanghai BDgene Therapeutics is a biotechnology company engaged in research and development of gene therapies for the treatment of genetic diseases. The company is headquartered in Shanghai City, ...

Some patients with ocular hypertension who develop primary open angle glaucoma experience rapid visual field loss.

Bausch + Lomb announced the acquisition of the ELIOS system, a laser-based technology that offers a new approach to treating glaucoma, particularly in conjunction with cataract surgery. According to ...

Sigma-2 receptor modulation using exogenous ligands reduces cellular damage associated with central nervous system degeneration in age-related pathologies such as Alzheimer’s disease, Parkinson’s ...

Iantrek’s CREST Registry reports 1-year outcomes for a bio-interventional glaucoma treatment, demonstrating significant IOP ...

The glaucoma treatment landscape is shifting towards advanced surgical options, fueled by an aging population and greater ...